FDA Orange Book · active-ingredient family
Magnesium sulfate; polyethylene glycol 3350; potassium chloride; sodium chloride; sodium sulfate
Magnesium sulfate; polyethylene glycol 3350; potassium chloride; sodium chloride; sodium sulfate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:SUFLAVE · NDA 215344
1
Brand (NDA)
0
Generics (ANDA)
4
Listed patents
1
Exclusivity periods
Brand (NDA) products · for solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SUFLAVERLD | AZURITY | NDA 215344 | — | Jun 15, 2023 |
Marketing exclusivity (1)
- NPNew product exclusivity (3 years)
Jun 15, 2026
4 d ago
Listed patents (4)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12433914 | Jun 14, 2044 | in 18 yr 3 mo | U-4143 |
| 12239659 | Jun 14, 2044 | in 18 yr 3 mo | U-4143 |
| 12594298 | Jun 14, 2044 | in 18 yr 3 mo | Product |
| 12290529 | Aug 02, 2044 | in 18 yr 5 mo | Product |
Magnesium sulfate; polyethylene glycol 3350; potassium chloride; sodium chloride; sodium sulfate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

